Author:
Daudelin Denise H.,Peterson Laura E.,Selker Harry P.
Abstract
Abstract
Failure to accrue participants into clinical trials incurs economic costs, wastes resources, jeopardizes answering research questions meaningfully, and delays translating research discoveries into improved health. This paper reports the results of a pilot test of the Median Accrual Ratio (MAR) metric developed as a part of the Common Metrics Initiative of the NIH’s National Center for Advancing Translational Science (NCATS) Clinical and Translational Science Award (CTSA) Consortium. Using the metric is intended to enhance the ability of the CTSA Consortium and its “hubs” to increase subject accrual into trials within expected timeframes. The pilot test was undertaken at Tufts Clinical and Translational Science Institute (CTSI) with eight CTSA Consortium hubs. We describe the pilot test methods, and results regarding feasibility of collecting metric data and the quality of data that was collected. Participating hubs welcomed the opportunity to assess accrual efforts, but experienced challenges in collecting accrual metric data due to insufficient infrastructure and inconsistent implementation of electronic data systems and lack of uniform data definitions. Also, the metric could not be constructed for all trial designs, particularly those using competitive enrollment strategies. We offer recommendations to address the identified challenges to facilitate progress to broad accrual metric data collection and use.
Publisher
Cambridge University Press (CUP)
Reference13 articles.
1. 10. CTSA Program Common Metrics Operational Guideline: Median Accrual Ratio [Internet]. National Center for Advancing Translational Sciences. 2019 [cited 2020 Apr 15]. Available from: (https://clic-ctsa.org/sites/default/files/2019-09/Median%20Accrual%20Ratio%20Metric%20Operational%20Guidelines_6.pdf)
2. Implementing Common Metrics across the NIH Clinical and Translational Science Awards (CTSA) consortium
3. Clinical Trial Accrual: Obstacles and Opportunities
4. Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015
5. 13. Adapted from: Measure Evaluation Criteria and Guidance for Evaluating Measures for Endorsement. National Quality Forum; 2016 Aug.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献